These findings suggest a correlation between susceptibility to CMS-induced anhedonia and changes in BDNF levels, synaptic plasticity, and glutamate release in the PFC, offering potential strategies for the early prediction of stress-induced depression. The gene discussed is BDNF; the disease is depressive symptom measurement.